What Xaira Therapeutics does
Xaira Therapeutics develops artificial intelligence to discover and develop new medicines. The company builds predictive and agentic AI models that span the full drug discovery and development process, aiming to improve how therapeutic targets are chosen, designed, and matched to the right patients.
Key capabilities
A central product, X-Cell, is a virtual cell model trained on billions of genomic data points, including a large genome-wide perturbation dataset called X-Atlas Pisces. The model is designed to predict optimal biological targets, identify the most effective therapeutic modulations for those targets, and match medicines to appropriate patient populations and disease states. The company states its AI approach is intended to increase the probability of treatment success while reducing development timelines and costs.
Who it's for
Xaira's AI-driven drug discovery work is aimed at pharmaceutical and biotech development. The company is based in South San Francisco, California.